Literature DB >> 20060723

Mycobacterium abscessus: a new player in the mycobacterial field.

Halima Medjahed1, Jean-Louis Gaillard, Jean-Marc Reyrat.   

Abstract

Mycobacterium abscessus, a relative of Koch's bacillus (the bacterium that causes tuberculosis), has recently emerged as the cause of an increasing number of both community- and hospital-acquired infections in humans; it also constitutes a serious threat for cystic fibrosis patients. This situation is worsened by its exceptionally high natural and acquired antibiotic resistance that complicates treatment. Although a rapid grower, it shares some traits with Koch's bacillus, including the ability to induce a persistent lung disease associated with caseous lesions, a landmark of Mycobacterium tuberculosis infection. Its genome sequence and microarrays are now available, and efficient genetic tools have recently been developed. Here we consider the various advantages of using this species as an experimental model to study tuberculosis and other related mycobacterial diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20060723     DOI: 10.1016/j.tim.2009.12.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  70 in total

1.  Development of a rapid ATP bioluminescence assay for biocidal susceptibility testing of rapidly growing mycobacteria.

Authors:  Renuka Kapoor; Jagjit S Yadav
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

2.  Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group.

Authors:  Natalia Fernandes Garcia de Carvalho; Daisy Nakamura Sato; Fernando R Pavan; Lucilaine Ferrazoli; Erica Chimara
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

3.  Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory.

Authors:  Alejandro Sánchez-Chardi; Francesc Olivares; Thomas F Byrd; Esther Julián; Cecilia Brambilla; Marina Luquin
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

4.  Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

Authors:  Audrey Bernut; Jean-Louis Herrmann; Karima Kissa; Jean-François Dubremetz; Jean-Louis Gaillard; Georges Lutfalla; Laurent Kremer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

5.  Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.

Authors:  Maher Y Abdalla; Barbara L Switzer; Christopher H Goss; Moira L Aitken; Pradeep K Singh; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

6.  [Unclear liver lesions in a 19-year-old woman with acute myeloid leukemia].

Authors:  B Braun; A P Karl; C Dierkes; M Schenk; J Braess
Journal:  Internist (Berl)       Date:  2016-11       Impact factor: 0.743

7.  Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos.

Authors:  Audrey Bernut; Christian Dupont; Alain Sahuquet; Jean-Louis Herrmann; Georges Lutfalla; Laurent Kremer
Journal:  J Vis Exp       Date:  2015-09-09       Impact factor: 1.355

8.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections.

Authors:  Claudia Cortesia; Gustavo J Lopez; Jacobus H de Waard; Howard E Takiff
Journal:  J Antimicrob Chemother       Date:  2010-10-06       Impact factor: 5.790

10.  The first structure of a mycobacteriophage, the Mycobacterium abscessus subsp. bolletii phage Araucaria.

Authors:  Mohamed Sassi; Cecilia Bebeacua; Michel Drancourt; Christian Cambillau
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.